Доступ предоставлен для: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems
Главный редактор: Mandip Sachdeva Singh (open in a new tab)

Выходит 6 номеров в год

ISSN Печать: 0743-4863

ISSN Онлайн: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Recent Developments of Biodegradable and Biocompatible Materials Based Micro/Nanoparticles for Delivering Macromolecular Therapeutics

Том 26, Выпуск 1, 2009, pp. 29-84
DOI: 10.1615/CritRevTherDrugCarrierSyst.v26.i1.20
Get accessGet access

Краткое описание

Developments in biotechnology have seen the growing use of macromolecules containing proteins, peptides, vaccines, antigens, genes, and growth factors as therapeutic agents. Because these macromolecules are easily denatured and metabolized rapidly in vivo, their protection and controlled release are required. Biodegradable and biocompatible materials based micro/nanoparticles (MPs/NPs) show great potential for delivering macromolecular therapeutics. One of the greatest challenges in the delivery of macromolecules from biodegradable and biocompatible MPs/NPs is the controlled and complete release of the drugs in their native forms. Unfortunately, the present drug delivery systems cannot satisfy the requirement; thus, more research is expected. This article discusses the recent developments in the field of macromolecular delivery.

ЦИТИРОВАНО В
  1. Gutiérrez Andres H., Spero Denice, Gay Cyril, Zimic Mirko, De Groot Anne S., New vaccines needed for pathogens infecting animals and humans, Human Vaccines & Immunotherapeutics, 8, 7, 2012. Crossref

  2. Keselowsky Benjamin G., Xia Chang Qing, Clare-Salzler Michael, Multifunctional dendritic cell-targeting polymeric microparticles, Human Vaccines, 7, 1, 2011. Crossref

  3. Lv Bo, Wang Yue, Chen Wei, Preparation, Characterization, and Bioactivity of Chitosan Microspheres Containing Basic Fibroblast Growth Factor, Journal of Nanomaterials, 2014, 2014. Crossref

  4. De Smet Rebecca, Allais Liesbeth, Cuvelier Claude A, Recent advances in oral vaccine development, Human Vaccines & Immunotherapeutics, 10, 5, 2014. Crossref

  5. Hudalla Gregory A., Murphy William L., Biomaterials that Regulate Growth Factor Activity via Bioinspired Interactions, Advanced Functional Materials, 21, 10, 2011. Crossref

  6. Wang Ji-Yun, Jin Yao, Xie Rui, Liu Jie-Yi, Ju Xiao-Jie, Meng Tao, Chu Liang-Yin, Novel calcium-alginate capsules with aqueous core and thermo-responsive membrane, Journal of Colloid and Interface Science, 353, 1, 2011. Crossref

  7. Ji Wei, Sun Yan, Yang Fang, van den Beucken Jeroen J. J. P., Fan Mingwen, Chen Zhi, Jansen John A., Bioactive Electrospun Scaffolds Delivering Growth Factors and Genes for Tissue Engineering Applications, Pharmaceutical Research, 28, 6, 2011. Crossref

  8. Evjen Tove Julie, Nanomedisin i kreftbehandling – håp til små partikler, Tidsskrift for Den norske legeforening, 135, 18, 2015. Crossref

  9. Levy Ido, Magdassi Shlomo, Mandler Daniel, Potential induced pH change: Towards electrochemical coating of medical implants by organic nanoparticles, Electrochimica Acta, 55, 28, 2010. Crossref

  10. Zhang Zhiyue, Huang Guihua, Micro- and Nano-Carrier Mediated Intra-Articular Drug Delivery Systems for the Treatment of Osteoarthritis, Journal of Nanotechnology, 2012, 2012. Crossref

  11. Ibrahim Howida Kamal, Fahmy Rania Hassan, Localized rosuvastatin via implantable bioerodible sponge and its potential role in augmenting bone healing and regeneration, Drug Delivery, 23, 9, 2016. Crossref

  12. Matus María Francisca, Vilos Cristian, Cisterna Bruno A., Fuentes Eduardo, Palomo Iván, Nanotechnology and primary hemostasis: Differential effects of nanoparticles on platelet responses, Vascular Pharmacology, 101, 2018. Crossref

  13. Dixit Saurabh, Sahu Rajnish, Verma Richa, Duncan Skyla, Giambartolomei Guillermo H., Singh Shree R., Dennis Vida A., Caveolin-mediated endocytosis of the Chlamydia M278 outer membrane peptide encapsulated in poly(lactic acid)-Poly(ethylene glycol) nanoparticles by mouse primary dendritic cells enhances specific immune effectors mediated by MHC class II and CD4+ T cells, Biomaterials, 159, 2018. Crossref

  14. Vetvicka Vaclav, Vannucci Luca, Sima Petr, β‐glucan as a new tool in vaccine development, Scandinavian Journal of Immunology, 91, 2, 2020. Crossref

  15. Nakajima Nao, Hashimoto Satoru, Sato Hiroki, Takahashi Kazuya, Nagoya Takuro, Kamimura Kenya, Tsuchiya Atsunori, Yokoyama Junji, Sato Yuichi, Wakatsuki Hanako, Miyata Masayuki, Akashi Yusuke, Tanaka Ryusuke, Matsuda Ken, Tabata Yasuhiko, Terai Shuji, Efficacy of gelatin hydrogels incorporating triamcinolone acetonide for prevention of fibrosis in a mouse model, Regenerative Therapy, 11, 2019. Crossref

  16. Verma Richa, Sahu Rajnish, Singh Desh Deepak, Egbo Timothy E., A CRISPR/Cas9 based polymeric nanoparticles to treat/inhibit microbial infections, Seminars in Cell & Developmental Biology, 96, 2019. Crossref

  17. Fonte Pedro, Andrade José Carlos, Seabra Vítor, Sarmento Bruno, Chitosan-Based Nanoparticles as Delivery Systems of Therapeutic Proteins, in Therapeutic Proteins, 899, 2012. Crossref

  18. Sharma Ankur, Jha Niraj Kumar, Dahiya Kajal, Singh Vivek Kumar, Chaurasiya Kundan, Jha Aditya Narayan, Jha Saurabh Kumar, Mishra Prabhu Chandra, Dholpuria Sunny, Astya Rani, Nand Parma, Kumar Amit, Ruokolainen Janne, Kesari Kavindra Kumar, Nanoparticulate RNA delivery systems in cancer, Cancer Reports, 3, 5, 2020. Crossref

  19. Wu Yuye, Battalapalli Dheerendranath, Hakeem Mohammed J., Selamneni Venkatarao, Zhang Pengfei, Draz Mohamed S., Ruan Zhi, Engineered CRISPR-Cas systems for the detection and control of antibiotic-resistant infections, Journal of Nanobiotechnology, 19, 1, 2021. Crossref

  20. Bachmann Martin F., Jennings Gary T., Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns, Nature Reviews Immunology, 10, 11, 2010. Crossref

  21. Luo Li, Qin Tao, Huang Yifan, Zheng Sisi, Bo Ruonan, Liu Zhenguang, Xing Jie, Hu Yuanliang, Liu Jiaguo, Wang Deyun, Exploring the immunopotentiation of Chinese yam polysaccharide poly(lactic-co-glycolic acid) nanoparticles in an ovalbumin vaccine formulation in vivo, Drug Delivery, 24, 1, 2017. Crossref

Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции Цены и условия подписки Begell House Контакты Language English 中文 Русский Português German French Spain